Niki BioSolutions, Inc. Net Change in Cash
Niki BioSolutions, Inc. (NIKI) reported Net Change in Cash of $2.58 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-05-11
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 10 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.58M S-4/A · filed 2026-05-11 | |||
| 2025-09-30 | $1.40M 6-K · filed 2026-01-22 | |||
| 2025-06-30 | $1.88M 6-K · filed 2025-10-08 | |||
| 2024-12-31 | -$1.13M S-4/A · filed 2026-05-11 | |||
| 2024-09-30 | -$1.25M 6-K · filed 2026-01-22 | |||
| 2024-06-30 | -$1.22M 6-K · filed 2025-10-08 | |||
| 2023-12-31 | -$3.01M S-4/A · filed 2026-05-11 | |||
| 2023-06-30 | -$4.54M 6-K · filed 2023-12-22 | |||
| 2022-12-31 | -$3.25M 6-K · filed 2025-10-08 | |||
| 2022-06-30 | -$1.07M 6-K · filed 2023-12-22 | |||
| 2021-12-31 | $4.64M 20-F · filed 2023-04-28 | |||
| 2021-06-30 | $16.44M 6-K · filed 2022-09-30 | |||
| 2020-12-31 | -$1.67M 20-F · filed 2023-04-28 | |||
| 2020-06-30 | -$1.17M 6-K · filed 2021-09-15 | |||
| 2019-12-31 | -$20.81M 20-F/A · filed 2023-01-17 | |||
| 2018-12-31 | $9.38M 20-F · filed 2021-04-19 | |||
| 2017-12-31 | $16.10M 20-F · filed 2020-04-29 |